Electrophysiological findings in neurofibromatosis type 1

Journal of the Neurological Sciences

Volumn 306, Issue 1-2, 2011, Pages 42-48

  Yerdelen, Deniz ^a   Koc, Filiz ^b   Durdu, Murat ^a   Karakas, Mehmet ^b  

^a BASKENT UNIVERSITY   (Turkey)

^b CUKUROVA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Electrophysiological findings; Neurofibromatosis type 1

Indexed keywords

ADULT; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONFERENCE PAPER; ELECTROMYOGRAPHY; ELECTRONEUROMYOGRAPHY; ELECTROPHYSIOLOGY; EVOKED BRAIN STEM AUDITORY RESPONSE; EVOKED SOMATOSENSORY RESPONSE; EVOKED VISUAL RESPONSE; FEMALE; HUMAN; MALE; NEUROFIBROMATOSIS; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; CHILD; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; ELECTROPHYSIOLOGICAL PHENOMENA; EVOKED POTENTIALS; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUSCLE, SKELETAL; NEUROFIBROMATOSIS 1; NEUROLOGIC EXAMINATION; YOUNG ADULT;

EID: 79958741078     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2011.03.048     Document Type: Conference Paper

References (24)

1. North K, Cochineas C, Tang E, Fagan E. Optic gliomas in neurofibromatosis type 1: role of visual evoked potentials. Pediatr Neurol 1994;10:117-23. (Pubitemid 24113313)
2. Friedman JM. Neurofibromatosis 1: clinical manifestations and diagnostic criteria. J Child Neurol 2002;17:548-54. (Pubitemid 35203613)
3. Lynch TM, Gutmann DH. Neurofibromatosis 1. Neurol Clin 2002;20:841-65. (Pubitemid 35154470)
4. Ferner RE, Hughes RA, Hall SM, Upadhyaya M, Johnson MR. Neurofibromatous neuropathy in neurofibromatosis 1 (NF1). J Med Genet 2004;41:837-41. (Pubitemid 39524310)
5. Ammendola A, Ciccone G, Ammendola E. Utility of multimodal evoked potentials study in neurofibromatosis type 1 of childhood. Pediatr Neurol 2006;34:276-80.
6. Margari L, Presicci A, Ventura P, Maria Bacca S, Iliceto G, Medicamento N, et al. Clinical and Instrumental (magnetic resonance imaging [MRI] and multimodal evoked potentials) follow-up of brain lesions in three young patients with neurofibromatosis 1. J Child Neurol 2006;21:1085-90. (Pubitemid 46128367)
7. Drouet A, Wolkenstein P, Lefaucheur JP, Pinson S, Combemale P, Gherardi RK, et al. Neurofibromatosis 1-associated neuropathies: a reappraisal. Brain 2004;127:1993-2009. (Pubitemid 39150258)
8. Neurofibromatosis: Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol 1988;45:575-8.
9. Schiff JA, Cracco PQ, Cracco JB. Brainstem auditory evoked potentials in Guillain-Barré syndrome. Neurology 1985;35:771-3. (Pubitemid 15067044)
10. Cracco RQ, Cracco JB. Somatosensory evoked potential in man: far field potentials. Electroencephalogr Clin Neurophysiol 1976;41:460-6.
11. Cracco RQ, Cracco JB. Visual evoked potentials in man: early oscillatory potentials. Electroencephalogr Clin Neurophysiol 1978;45:731-9. (Pubitemid 9072642)
12. Iannaccone A, McCluney RA, Brewer VR, Spiegel PH, Taylor JS, Kerr NC, et al. Visual evoked potentials in children with neurofibromatosis type 1. Doc Ophthalmol 2002;105:63-81. (Pubitemid 34711989)
13. Wolsey DH, Larson SA, Creel D, Hoffman R. Can screening for optic nerve gliomas in patients with neurofibromatosis type I be performed with visual-evoked potential testing? JAAPOS 2006;10:307-11.
14. Duffner PK, Cohen ME, Seidel FG, Shucard DW. The significance of MRI abnormalities in children with neurofibromatosis. Neurology 1989;39:373-8. (Pubitemid 19094728)
15. Ko KF. The role of evoked potential and MR imaging in assessing multiple sclerosis: a comparative study. Singapore Med J 2010;51(9):716-20.
16. Rizzo PA, Valle E, Mollica MA, Sanarelli L, Pozzessere G. Multimodal evoked potentials in neuro-Behçet: a longitudinal study of two cases. Acta Neurol Scand 1989;79(1):18-22. (Pubitemid 19053623)
17. DeBella K, Poskitt K, Szudek J, Friedman JM. Use of "unidentified bright objects" on MRI for diagnosis of neurofibromatosis 1 in children. Neurology 2000;54:1646-51.
18. Ferner RE, Chaudhuri R, Bingham J, Cox T, Hughes RA. MRI in neurofibromatosis 1. The nature and evolution of increased intensity T2 weighted lesions and their relationship to intellectual impairment. J Neurol Neurosurg Psychiatry 1993;56(5):492-5. (Pubitemid 23171779)
19. Aoki S, Barkovich AJ, Nishimura K, Kjos BO, Machida T, Cogen P, et al. Neurofibromatosis types 1 and 2: cranial MR findings. Radiology 1989;172(2):527-34. (Pubitemid 19184901)
20. Roos KL, Pascuzzi RM, Dunn DW. Neurofibromatosis, Charcot-Marie-Tooth disease, or both? Neurofibromatosis 1989;2:238-43.
21. Lupski JR, Pentao L, Williams LL, Patel PI. Stable inheritance of the CMT1A DNA duplication in two patients with CMT1 and NF1. Am J Med Genet 1993;45:92-6. (Pubitemid 23017993)
22. Koc F, Guzal A?. Neurofibromatosis type 1 associated with Charcot-Marie-Tooth type 1A. J Dermatol 2009;36:306-11.
23. Tedesco MA, Di Salvo G, Natale F, Pergola V, Calabrese E, Grassia C, et al. The heart in neurofibromatosis type 1: an echocardiographic study. Am Heart J 2002;143:883-8. (Pubitemid 34595349)
24. Zacharia TT, Jaramillo D, Poussaint TY, Korf B. MR imaging of abdominopelvic involvement in neurofibromatosis type 1: a review of 43 patients. Pediatr Radiol 2005;35:317-22. (Pubitemid 40425056)